Mancilla Bethany 4
4 · Cue Biopharma, Inc. · Filed Aug 2, 2018
Insider Transaction Report
Form 4
Mancilla Bethany
SVP and Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2018-08-01+250,000→ 250,000 totalExercise: $9.54Exp: 2025-08-01→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning February 1, 2019.